Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.

ABSTRACT:

SUBMITTER: Palandri F 

PROVIDER: S-EPMC10155661 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature